Julie Smith Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Julie Smith.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Julie Smith. Julie Smith is EVP, Strategy and COO in Raptor Pharmaceutical Corp ($RPTP) and President and CEO in Raptor Pharmaceutical Corp ($RPTP) and Director in EXELIXIS, INC. ($EXEL) and Director in Stoke Therapeutics, Inc. ($STOK) and Director in Audentes Therapeutics, Inc. ($BOLD).
Latest Insider Trading Transactions of Julie Smith
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BOLD, EXEL, RPTP, STOK
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 05 2020 | STOK | Stoke Therapeutics ... | Smith Julie | Director | Option Exercise | A | 26.53 | 29,555 | 784,094 | 29,555 | |
May 22 2020 | EXEL | EXELIXIS, INC. | Smith Julie | Director | Grant | A | 0.00 | 15,538 | 0 | 16,301 | 763 to 16.3 K (+2,036.44 %) |
May 22 2020 | EXEL | EXELIXIS, INC. | Smith Julie | Director | Grant | A | 0.00 | 15,538 | 0 | 16,301 | 763 to 16.3 K (+2,036.44 %) |
Jan 15 2020 | BOLD | Audentes Therapeut ... | Smith Julie | Director | Option Exercise | D | 24.74 | 16,200 | 400,788 | 0 | |
Jan 15 2020 | BOLD | Audentes Therapeut ... | Smith Julie | Director | Option Exercise | D | 38.65 | 10,000 | 386,500 | 0 | |
Jan 15 2020 | BOLD | Audentes Therapeut ... | Smith Julie | Director | Option Exercise | D | 26.15 | 9,000 | 235,350 | 0 | |
Jan 15 2020 | BOLD | Audentes Therapeut ... | Smith Julie | Director | Option Exercise | D | 17.85 | 18,000 | 321,300 | 0 | |
May 24 2019 | EXEL | EXELIXIS, INC. | Smith Julie | Director | Option Exercise | A | 19.77 | 42,641 | 843,013 | 42,641 | |
Feb 08 2019 | BOLD | Audentes Therapeut ... | Smith Julie | Director | Option Exercise | A | 24.74 | 16,200 | 400,788 | 16,200 | |
Jun 08 2018 | BOLD | Audentes Therapeut ... | Smith Julie | Director | Option Exercise | A | 38.65 | 10,000 | 386,500 | 10,000 | |
May 24 2018 | EXEL | EXELIXIS, INC. | Smith Julie | Director | Option Exercise | A | 20.50 | 31,167 | 638,924 | 31,167 | |
May 24 2018 | EXEL | EXELIXIS, INC. | Smith Julie | Director | Option Exercise | A | 20.50 | 31,167 | 638,924 | 31,167 | |
Oct 10 2017 | BOLD | Audentes Therapeut ... | Smith Julie | Director | Option Exercise | A | 26.01 | 9,000 | 234,090 | 9,000 | |
May 26 2017 | EXEL | EXELIXIS, INC. | Smith Julie | Director | Option Exercise | A | 19.57 | 23,491 | 459,719 | 23,491 | |
Feb 24 2017 | EXEL | EXELIXIS, INC. | Smith Julie | Director | Option Exercise | A | 21.74 | 16,620 | 361,319 | 16,620 | |
Jan 05 2017 | BOLD | Audentes Therapeut ... | Smith Julie | Director | Option Exercise | A | 17.85 | 18,000 | 321,300 | 18,000 | |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Smith Julie | President and CEO | Option Exercise | D | 3.74 | 240,595 | 899,825 | 0 | |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Smith Julie | President and CEO | Option Exercise | D | 8.13 | 175,000 | 1,422,750 | 0 | |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Smith Julie | President and CEO | Option Exercise | D | 5.27 | 152,050 | 801,304 | 0 | |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Smith Julie | President and CEO | Sell | D | 9.00 | 64,179 | 577,611 | 0 | 64.2 K to 0 (-100.00 %) |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Smith Julie | President and CEO | Sell | U | 9.00 | 45,759 | 411,831 | 64,179 | 109.9 K to 64.2 K (-41.62 %) |
Sep 26 2016 | EXEL | EXELIXIS, INC. | Smith Julie | Director | Option Exercise | A | 14.74 | 26,000 | 383,240 | 26,000 | |
Sep 26 2016 | EXEL | EXELIXIS, INC. | Smith Julie | Director | Grant | A | 0.00 | 763 | 0 | 763 | 0 to 763 |
Feb 11 2016 | RPTP | Raptor Pharmaceuti ... | Smith Julie | President and CEO | Option Exercise | A | 3.74 | 240,595 | 899,825 | 240,595 | |
Feb 11 2016 | RPTP | Raptor Pharmaceuti ... | Smith Julie | President and CEO | Grant | A | 0.00 | 64,179 | 0 | 102,129 | 38 K to 102.1 K (+169.11 %) |
Sep 12 2012 | RPTP | Raptor Pharmaceuti ... | Smith Julie | EVP, Strategy and C ... | Option Exercise | A | 5.27 | 190,000 | 1,001,300 | 190,000 |
Page: 1